FDA
- Status: approved
recombinant human hyaluronidase PH20 (recombinant human hyaluronidase PH20) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Halozyme Therapeutics is the originator. The local marketing authorisation holder may differ — check the official source linked above.